GVK Biosciences appoints Dr. John Ellingboe as Senior Vice President, Discovery Chemistry
GVK Biosciences announced that Dr. John Ellingboe has been appointed as Senior Vice President, Discovery chemistry. Dr. Ellingboe will report to Mr. Manni Kantipudi, President, GVK Biosciences.
Prior to joining GVK BIO, Dr. Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and drug discovery. During the course of his time at Wyeth, he established a core parallel synthesis group, a lead identification group, and an integrated medicinal chemistry group working in all phases of drug discovery. His responsibilities included the identification of leads and development candidates across multiple therapeutic areas and leading a department across several research sites. The chemistry group worked closely with screening sciences, computational chemistry, X-ray crystallography, and drug safety and metabolism groups to identify optimal development candidates. While at Wyeth, he initiated and managed a large chemistry partnership with GVK BIO. Dr. Ellingboe received his undergraduate degree in Chemistry from Reed College and a Ph.D. in Organic Chemistry from MIT. He has over 150 publications, presentations and patents to his name.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
